Harnessing the Immune System to Fight Multiple Myeloma

Harnessing the Immune System to Fight Multiple Myeloma

Multiple myeloma (MM) is a heterogeneous plasma cell malignancy differing substantially in clinical behavior, prognosis, and response to treatment. With the advent of novel therapies, many patients achieve long-lasting remissions, but some experience aggressive and treatment refractory relapses. So...

Full description

Bibliographic Details
Main Authors: Jakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold, Thomas Stauffer Larsen, Torben Barington, Niels Abildgaard
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
multiple myeloma
immunotherapy
immune modulation
allogeneic stem cell transplantation
cancer vaccination
adoptive cell transfer
Online Access:https://www.mdpi.com/2072-6694/13/18/4546

Internet

https://www.mdpi.com/2072-6694/13/18/4546

Similar Items